Lipid Disorders
From the Journals
ApoB may better predict mortality risk in statin-treated patients
In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial...
Conference Coverage
PCOS equivalent in men: No ovaries required
Conference Coverage
High-intensity interval training cuts cardiometabolic risks in women with PCOS
From the Journals
Ultraprocessed foods, many marketed as healthy, raise CVD risk
From the Journals
Dose-related AFib risk with omega-3 fatty acids?
The VITAL-RHYTHM study, showing no significant effect of low-dose omega-3 fatty acids or vitamin D on AFib risk, has been published. A look at...
Feature
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
From the Journals
Type 2 diabetes linked to increased risk for Parkinson’s
Both observational and genetic data have provided “convincing evidence” that T2D predisposes people to an increased risk for Parkinson’s disease...
Conference Coverage
Evidence grows for food as RA treatment
An enhanced anti-inflammatory diet shows promise for symptom reduction.
From the Journals
Eating fish tied to fewer CVD events in high-risk people
A report shows a significant link between eating two fish meals a week and fewer cardiovascular disease events for those with or at high risk for...
From the Journals
Obesity: A ‘double hit’ in pregnant women with heart disease
Maternal obesity may prove to be the Achilles’ heel of sustainable national efforts to reduce maternal mortality and improve health equity,...
From the Journals
Semaglutide for meaningful weight loss in obesity and diabetes?
“This is by far the best result we had with any weight loss medicine in patients with diabetes,” says the senior author of the STEP 2 clinical...